IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 103 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1COMPARISON OF GONIOSCOPY AND ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY IN THE ASSESSMENT OF ANTERIOR CHAMBER ANGLE IN GLAUCOMATOUS PATIENTS OF A TERTIARY CARE HOSPITAL OF KUMAOUN REGION
Snigdha Joshi,Vimlesh Sharma,Shanti Pandey,Govind Singh Titiyal
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2021;()20
[DOI]
2Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model
Maria Kalogerou,Panagiotis Kolovos,Ekatherine Prokopiou,Gregory Papagregoriou,Constantinos Deltas,Stavros Malas,Tassos Georgiou
Experimental Eye Research.2018;167()128
[DOI]
3Cross-Amplification of Vicia sativa subsp. sativa Microsatellites across 22 Other Vicia Species
Sebastin Raveendar,Gi-An Lee,Young-Ah Jeon,Yun Lee,Jung-Ro Lee,Gyu-Taek Cho,Joon-Hyeong Cho,Jong-Hyun Park,Kyung-Ho Ma,Jong-Wook Chung
Molecules.2015;20(1)1543
[DOI]
4Cross-Amplification of Vicia sativa subsp. sativa Microsatellites across 22 Other Vicia Species
Thirumurthy Velpandian,Aruna Singh,Rama Jayasundar
Molecules.2016;20(1)517
[DOI]
5Associations between personality traits and adherence to treatment in patients with primary open–angle glaucoma in an African population
Emmanuel K Abu,Ebenezer O Antiri,Stephen Ocansey,Michael Ntodie,Samuel Abokyi,Carl Halladay Abraham
Clinical and Experimental Optometry.2022;20(1)1
[DOI]
6Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
Nada M. El Hoffy,Engy A. Abdel Azim,Rania M. Hathout,Marwa A. Fouly,Seham A. Elkheshen
European Journal of Pharmaceutical Sciences.2021;158(1)105648
[DOI]
7Innovations and revolutions in reducing retinal ganglion cell loss in glaucoma
Mary Kelada,Daniel Hill,Timothy E. Yap,Haider Manzar,M. Francesca Cordeiro
Expert Review of Ophthalmology.2021;16(1)33
[DOI]
8Glaucoma Treatment and Hydrogel: Current Insights and State of the Art
Antonio Maria Fea,Cristina Novarese,Paolo Caselgrandi,Giacomo Boscia
Gels.2022;8(8)510
[DOI]
9Nucleotides in the Eye: Focus on Functional Aspects and Therapeutic Perspectives
Ana Guzman-Aranguez,Concepcion Santano,Alba Martin-Gil,Begoña Fonseca,Jesús Pintor
Journal of Pharmacology and Experimental Therapeutics.2013;345(3)331
[DOI]
10Contact Lens as Drug Delivery System for Glaucoma Treatment: A Review
Hassan A. Aljaberi,Zaydoon T. Mohammed Noori
The Open Ophthalmology Journal.2023;17(1)331
[DOI]
11Bimatoprost-Loaded Ocular Inserts as Sustained Release Drug Delivery Systems for Glaucoma Treatment: In Vitro and In Vivo Evaluation
Juçara Ribeiro Franca,Giselle Foureaux,Leonardo Lima Fuscaldi,Tatiana Gomes Ribeiro,Lívia Bomfim Rodrigues,Renata Bravo,Rachel Oliveira Castilho,Maria Irene Yoshida,Valbert Nascimento Cardoso,Simone Odília Fernandes,Sebastião Cronemberger,Anderson José Ferreira,André Augusto Gomes Faraco,Thomas Claudepierre
PLoS ONE.2014;9(4)e95461
[DOI]
12In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment
Mitchell A. Jackson,Jaya Giyanani,Yumna Shabaik,Jeff Penzner,Anuradha V. Gore,Michael R. Robinson,George O. Waring
Ophthalmology and Therapy.2022;11(2)869
[DOI]
13Three-dimensional simulation of biological ion channels under mechanical, thermal and fluid forces
Riccardo Sacco,Paolo Airoldi,Aurelio G. Mauri,Joseph W. Jerome
Applied Mathematical Modelling.2017;43(2)221
[DOI]
14Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Mihir Shah,Sara Cabrera-Ghayouri,Lori-Ann Christie,Katherine S. Held,Veena Viswanath
Pharmaceutical Research.2019;36(4)221
[DOI]
15Sustained release timolol maleate loaded ocusert based on biopolymer composite
Revathy V. Nair,Shefrin S,Akhil Suresh,Anoop K.R.,Sreeja C. Nair
International Journal of Biological Macromolecules.2018;110(4)308
[DOI]
16Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis
Raffaele Nuzzi,Federico Tridico
Frontiers in Neuroscience.2017;11(4)308
[DOI]
17Ocular prodrugs: Attributes and challenges
Jagpreet kour,Neha Kumari,Bharti Sapra
Asian Journal of Pharmaceutical Sciences.2021;16(2)175
[DOI]
18Natural products: A lead for drug discovery and development
Bhawna Chopra,Ashwani Kumar Dhingra
Phytotherapy Research.2021;35(9)4660
[DOI]
19Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma
Begoña Fonseca,Alejandro Martínez-Águila,María J. Pérez de Lara,Jesús Pintor
Purinergic Signalling.2017;13(2)171
[DOI]
20In vitro and ex vivo corneal penetration and absorption models
Priyanka Agarwal,Ilva D. Rupenthal
Drug Delivery and Translational Research.2016;6(6)634
[DOI]
21Intraocular pressure lowering effect and structure-activity relationship of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity
Adrian Julian Marcus,Igor Iezhitsa,Renu Agarwal,Pavel Vassiliev,Alexander Spasov,Olga Zhukovskaya,Vera Anisimova,Bushra Johari,Nafeeza Mohd Ismail
European Journal of Pharmaceutical Sciences.2018;114(6)245
[DOI]
22A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Tali Fishman Jacob,Vijay Singh,Mudit Dixit,Tamar Ginsburg-Shmuel,Begoña Fonseca,Jesus Pintor,Moussa B. H. Youdim,Dan T. Major,Orly Weinreb,Bilha Fischer
Purinergic Signalling.2018;14(3)271
[DOI]
23Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma
Alejandro Martínez-Águila,Alba Martín-Gil,Carlos Carpena-Torres,Cristina Pastrana,Gonzalo Carracedo
Biomolecules.2021;11(3)340
[DOI]
24Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia
Francis W. Price,Milton Hom,Majid Moshirfar,David Evans,Haixia Liu,Jeff Penzner,Michael R. Robinson,Sungwook Lee,David L. Wirta
Ophthalmology Science.2021;1(4)100065
[DOI]
25AAV2-Mediated Expression of HspB1 in RGCs Prevents Somal Damage and Axonal Transport Deficits in a Mouse Model of Ocular Hypertension
Mi-Hyun Nam,Rooban B. Nahomi,Mina B. Pantcheva,Armaan Dhillon,Vince A. Chiodo,W. Clay Smith,Ram H. Nagaraj
Translational Vision Science & Technology.2022;11(11)8
[DOI]
26Exploring of Taguchi Design in the Optimization of Brinzolamide and Timolol Maleate Ophthalmic in-situ Gel Used in Treatment of Glaucoma
Purvi Shah,Vaishali Thakkar,Vishvas Anjana,Jenee Christian,Roma Trivedi,Kalpana Patel,Mukesh Gohel,Tejal Gandhi
Current Drug Therapy.2020;15(5)524
[DOI]
27Tissue-Engineered Models for Glaucoma Research
Renhao Lu,Paul Soden,Esak Lee
Micromachines.2020;11(6)612
[DOI]
28Modulated approaches for strategic transportation of proteins and peptides via ocular route
Maitri Bhatt,Pravin Shende
Journal of Drug Delivery Science and Technology.2021;66(6)102835
[DOI]
29Ophthalmic suspension of Brimonidine for sustained delivery using nano-resin/drug complex technique
Ajay J. Khopade,Arindam Halder,Vinod Burade,Bharat Pateliya,Kaushal Jani,Vivek Patel,Shivam Upadhyay
Journal of Drug Delivery Science and Technology.2022;75(6)103594
[DOI]
30A COMPARATIVE STUDY ON THE SAFETY AND EFFICACY OF TOPICAL BIMATOPROST WITH TIMOLOL MALEATE IN GLAUCOMA PATIENTS
Padma Polagani,Sridhar Venkat Maddikunta,Namala Balakrishna,Souris Kondaveti
Journal of Evolution of Medical and Dental Sciences.2016;5(46)2874
[DOI]
31Glaucoma: Current treatment and impact of advanced drug delivery systems
Khushwant S. Yadav,Rahul Rajpurohit,Sushmita Sharma
Life Sciences.2019;221(46)362
[DOI]
32Glaucoma management: relative value and place in therapy of available drug treatments
Deepak Sambhara,Ahmad A. Aref
Therapeutic Advances in Chronic Disease.2014;5(1)30
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow